Literature DB >> 15300342

Diagnostic accuracy of postnatal renal pelvic diameter as a predictor of uropathy: a prospective study.

Maria Cândida Ferrarez Bouzada1, Eduardo Araujo Oliveira, Alamanda Kfoury Pereira, Henrique Vitor Leite, Andréia Moura Rodrigues, Lívia Alvarenga Fagundes, Ricardo Peixoto Gonçalves, Ricardo Parreiras.   

Abstract

BACKGROUND: There is a necessity to standardize postnatal ultrasonographic markers predictive of significant uropathies. The purpose of this study was to assess the accuracy of anteroposterior renal pelvic diameter (APD) on postnatal ultrasound to discriminate between significant uropathy and idiopathic renal pelvic dilatation.
MATERIALS AND METHODS: Neonates ( n=110) who were found to have isolated fetal renal pelvic dilatation underwent systematic investigation and were prospectively followed up. A US scan was performed after the 1st week of life, and all infants underwent voiding cystourethrography. Neonates with an APD larger than 10 mm were examined with renal scintigraphy. Receiver-operating characteristic (ROC) plots were constructed to determine the best cutoffs for APD to identify renal units with significant uropathy as well as those requiring surgical intervention.
RESULTS: The area under the curve (AUC) estimated by the ROC curve was 0.921 (95% CI=0.869-0.957), indicating excellent discriminant power between nonsignificant pelvis dilatation and significant uropathy. A cutoff of 10 mm for APD showed the best accuracy for identifying infants with a significant uropathy (sensitivity, 90.4%; specificity, 91%). To identify infants who required surgical intervention, the calculated AUC was 0.976 (95% CI=0.940-0.993). A cutoff of 15 mm showed the best diagnostic performance for identifying the renal units requiring pyeloplasty (sensitivity, 100%; specificity, 92.5%).
CONCLUSION: Our results suggest that postnatal APD is an excellent test for identifying fetuses with significant uropathy, as well as those requiring postnatal intervention.

Entities:  

Mesh:

Year:  2004        PMID: 15300342     DOI: 10.1007/s00247-004-1283-8

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  32 in total

1.  Antenatal minimal hydronephrosis: is its follow-up an unnecessary cause of concern?

Authors:  L J Harding; P S Malone; D G Wellesley
Journal:  Prenat Diagn       Date:  1999-08       Impact factor: 3.050

Review 2.  Postnatal management of antenatal hydronephrosis.

Authors:  M Woodward; D Frank
Journal:  BJU Int       Date:  2002-01       Impact factor: 5.588

Review 3.  Antenatal hydronephrosis. Fetal and neonatal management.

Authors:  J S Elder
Journal:  Pediatr Clin North Am       Date:  1997-10       Impact factor: 3.278

4.  Can careful ultrasound examination of the urinary tract exclude vesicoureteric reflux in the neonate?

Authors:  E F Avni; K Ayadi; F Rypens; M Hall; C C Schulman
Journal:  Br J Radiol       Date:  1997-10       Impact factor: 3.039

Review 5.  Congenital uro-nephropathies: is routine voiding cystourethrography always warranted?

Authors:  F E Avni; M Hall; C C Schulman
Journal:  Clin Radiol       Date:  1998-04       Impact factor: 2.350

6.  Prognostic factors in fetal hydronephrosis: a multivariate analysis.

Authors:  E A Oliveira; J S Diniz; A C Cabral; H V Leite; E A Colosimo; R B Oliveira; A S Vilasboas
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

7.  Prognostic significance of antenatally detected fetal pyelectasis.

Authors:  J G Ouzounian; M A Castro; M Fresquez; O M al-Sulyman; B W Kovacs
Journal:  Ultrasound Obstet Gynecol       Date:  1996-06       Impact factor: 7.299

8.  Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population.

Authors:  Khalid Ismaili; Michelle Hall; Catherine Donner; Dominique Thomas; Danièle Vermeylen; Fred E Avni
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

Review 9.  Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

10.  Detection of obstructive uropathy in the fetus: predictive value of sonographic measurements of renal pelvic diameter at various gestational ages.

Authors:  N Anderson; T Clautice-Engle; R Allan; G Abbott; J E Wells
Journal:  AJR Am J Roentgenol       Date:  1995-03       Impact factor: 3.959

View more
  13 in total

1.  Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns.

Authors:  Batielhe F Melo; Marcos B Aguiar; Maria Candida F Bouzada; Regina L Aguiar; Alamanda K Pereira; Gabriela M Paixão; Mariana C Linhares; Flavia C Valerio; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2012-03-09       Impact factor: 3.714

2.  Clinical course of 822 children with prenatally detected nephrouropathies.

Authors:  Isabel G Quirino; Jose Silverio S Diniz; Maria Candida F Bouzada; Alamanda K Pereira; Thais J Lopes; Gabriela M Paixão; Natalia N Barros; Luisa C Figueiredo; Antonio Carlos V Cabral; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 8.237

3.  Clinical course of prenatally detected primary vesicoureteral reflux.

Authors:  José Maria Penido Silva; Eduardo Araujo Oliveira; José Silvério Santos Diniz; Maria Cândida Ferrarez Bouzada; Renata Moura Vergara; Barbara Caldeira Souza
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

4.  Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies.

Authors:  Mariana A Vasconcelos; Maria Candida F Bouzada; Katia D Silveira; Leticia R Moura; Fabiana F Santos; Juliana M Oliveira; Flavia F Carvalho; Mauro M Teixeira; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2011-02-18       Impact factor: 3.714

5.  Management in children of mild postnatal renal dilatation but without vesicoureteral reflux.

Authors:  Nigel G Anderson; Jesse Fischer; Diane Leighton; James Hector-Taylor; Rachael L McEwing
Journal:  Pediatr Nephrol       Date:  2010-03       Impact factor: 3.714

6.  Diagnostic accuracy of postnatal ultrasound screening for urinary tract abnormalities.

Authors:  Jan Hálek; Hana Flögelová; Kamila Michálková; Oldrich Smakal; Lubomír Dubrava; Jana Zapletalová; Vladimír Janout
Journal:  Pediatr Nephrol       Date:  2009-10-24       Impact factor: 3.714

7.  Outcome of isolated antenatal hydronephrosis: a prospective cohort study.

Authors:  Graziela M Coelho; Maria Candida F Bouzada; Alamanda K Pereira; Bruno F Figueiredo; Maria Rafaela S Leite; Danielly S Oliveira; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2007-07-26       Impact factor: 3.714

8.  A New Grading System for the Management of Antenatal Hydronephrosis.

Authors:  Joana Dos Santos; Rulan S Parekh; Tino D Piscione; Tarek Hassouna; Victor Figueroa; Paula Gonima; Isis Vargas; Walid Farhat; Norman D Rosenblum
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

9.  A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract.

Authors:  Isabel G Quirino; Cristiane S Dias; Mariana A Vasconcelos; Isabel V Poggiali; Kerlane C Gouvea; Alamanda K Pereira; Gabriela P Paulinelli; Amanda R Moura; Raquel S Ferreira; Enrico A Colosimo; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2014-06-19       Impact factor: 3.714

10.  Antenatal ultrasonographic anteroposterior renal pelvis diameter measurement: is it a reliable way of defining fetal hydronephrosis?

Authors:  Alamanda Kfoury Pereira; Zilma Silveira Nogueira Reis; Maria Cândida Ferrarez Bouzada; Eduardo Araújo de Oliveira; Gabriel Osanan; Antônio Carlos Vieira Cabral
Journal:  Obstet Gynecol Int       Date:  2011-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.